Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Beat The Street With SI Traders -- Ignore unavailable to you. Want to Upgrade?

To: ayeyou who wrote (129259)	1/5/2014 9:17:57 AM
From: Rocket Red	Respond to of 233836

for 6 hours away big difference - 17 to -35 without any wind

To: ayeyou who wrote (129259)	1/5/2014 11:08:59 AM
From: Rocket Red	Read Replies (1) \| Respond to of 233836

Marijuana discovery hints at how patients may benefit without suffering harmful side effects by Charlie Smith on Jan 4, 2014 at 11:54 am Story Some people in Vancouver might not want scientists tinkering with the high created by marijuana. Miranda Nelson It looks like French researchers have figured out how to negate the euphoria caused by smoking cannabis. [iframe style="BORDER-BOTTOM: 0px; BORDER-LEFT: 0px; VERTICAL-ALIGN: bottom; BORDER-TOP: 0px; BORDER-RIGHT: 0px" id=google_ads_iframe_1025923/Skyscraper_0 height=600 marginHeight=0 src="javascript:"<html]"" frameBorder=0 width=160 allowTransparency name=google_ads_iframe_1025923/Skyscraper_0 marginWidth=0 scrolling=no>[/iframe] In a paper published in the journal Science, scientists at the French Institute of Health and Medical Research point out that a naturally occurring hormone called pregnenolone has "been largely uninvestigated". However, in tests with laboratory mice, they discovered that it "reduces several effects of THC", the psychoactive agent in marijuana. Pregnenolone accomplishes this by inhibiting a receptor in the brain. According to the researchers, this discovery "could open an unforeseen approach for the treatment of cannabis intoxication and addiction". "These researchers weren't trying to be buzzkills," Science stated in an accompanying article. As medicinal marijuana becomes more widely accepted—even CNN's Dr. Sanjay Gupta has endorsed its efficacy—this research could help patients. Lead researcher Pier Vincenzo Piazza told the French news agency AFP that's because people receiving high doses risk impairments to brain development, memory, and lung function, and may be susceptible to addiction. Pregnenolone could diminish these harmful side effects. "We hope to be able to start clinical trials in people in a year to a year and a half," Piazza told AFP.